Skip to content

Clinical trials

Phase 1/2 Metabolic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Phase: Phase 1/2 Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20071
20091
20111
20121
20134
20142
20151
20162
20171
20191
20201
20212
20224
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting7
Terminated5
Active, not recruiting2
Withdrawn2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ModernaTX, Inc.3
4D Molecular Therapeutics2
LYSOGENE2
Washington University School of Medicine2
89bio, Inc.1
Alexion Pharmaceuticals, Inc.1
Baylor College of Medicine1
Diva De Leon1
Eledon Pharmaceuticals1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases29
Genetic Diseases, Inborn10
Lysosomal Storage Diseases6
Metabolism, Inborn Errors6
Nervous System Diseases5
Central Nervous System Diseases4
Diabetes Mellitus4
Immune System Diseases4
Mucopolysaccharidosis III4
Autoimmune Diseases3

Trials

Showing 76 to 29 of 29. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.